These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 11536046

  • 1. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG.
    Oncogene; 2001 Aug 30; 20(38):5341-9. PubMed ID: 11536046
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
    Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG.
    Cancer Res; 2002 Jun 01; 62(11):3276-81. PubMed ID: 12036945
    [Abstract] [Full Text] [Related]

  • 3. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
    Pierce AM, Fisher SM, Conti CJ, Johnson DG.
    Oncogene; 1998 Mar 12; 16(10):1267-76. PubMed ID: 9546428
    [Abstract] [Full Text] [Related]

  • 4. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS.
    Oncogene; 2000 Oct 19; 19(44):5054-62. PubMed ID: 11042693
    [Abstract] [Full Text] [Related]

  • 5. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB.
    Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672
    [Abstract] [Full Text] [Related]

  • 6. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL, Weaks RL, Berton TR, Johnson DG.
    Oncogene; 2006 Feb 09; 25(6):867-76. PubMed ID: 16205640
    [Abstract] [Full Text] [Related]

  • 7. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y, Zacksenhaus E.
    Oncogene; 2000 Dec 07; 19(52):6065-73. PubMed ID: 11146559
    [Abstract] [Full Text] [Related]

  • 8. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.
    Wang D, Russell J, Xu H, Johnson DG.
    Mol Carcinog; 2001 Jun 07; 31(2):90-100. PubMed ID: 11429786
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
    Budunova IV, Kowalczyk D, Pérez P, Yao YJ, Jorcano JL, Slaga TJ.
    Oncogene; 2003 May 22; 22(21):3279-87. PubMed ID: 12761498
    [Abstract] [Full Text] [Related]

  • 10. Direct repression of the Mcl-1 promoter by E2F1.
    Croxton R, Ma Y, Song L, Haura EB, Cress WD.
    Oncogene; 2002 Feb 21; 21(9):1359-69. PubMed ID: 11857079
    [Abstract] [Full Text] [Related]

  • 11. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

  • 12. The proliferative and apoptotic activities of E2F1 in the mouse retina.
    Lin SC, Skapek SX, Papermaster DS, Hankin M, Lee EY.
    Oncogene; 2001 Oct 25; 20(48):7073-84. PubMed ID: 11704831
    [Abstract] [Full Text] [Related]

  • 13. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
    Lindström MS, Wiman KG.
    Oncogene; 2003 Aug 07; 22(32):4993-5005. PubMed ID: 12902982
    [Abstract] [Full Text] [Related]

  • 14. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
    Elliott MJ, Dong YB, Yang H, McMasters KM.
    Clin Cancer Res; 2001 Nov 07; 7(11):3590-7. PubMed ID: 11705881
    [Abstract] [Full Text] [Related]

  • 15. Omomyc expression in skin prevents Myc-induced papillomatosis.
    Soucek L, Nasi S, Evan GI.
    Cell Death Differ; 2004 Sep 07; 11(9):1038-45. PubMed ID: 15143346
    [Abstract] [Full Text] [Related]

  • 16. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.
    Schuldiner O, Benvenisty N.
    Oncogene; 2001 Aug 16; 20(36):4984-94. PubMed ID: 11526483
    [Abstract] [Full Text] [Related]

  • 17. Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation.
    Berton TR, Mitchell DL, Guo R, Johnson DG.
    Oncogene; 2005 Apr 07; 24(15):2449-60. PubMed ID: 15735727
    [Abstract] [Full Text] [Related]

  • 18. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

  • 19. MIF loss impairs Myc-induced lymphomagenesis.
    Talos F, Mena P, Fingerle-Rowson G, Moll U, Petrenko O.
    Cell Death Differ; 2005 Oct 28; 12(10):1319-28. PubMed ID: 15947793
    [Abstract] [Full Text] [Related]

  • 20. Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS.
    Agger K, Santoni-Rugiu E, Holmberg C, Karlström O, Helin K.
    Oncogene; 2005 Jan 27; 24(5):780-9. PubMed ID: 15531911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.